Composition
- Active ingredients
- CIMETIDINE HYDROCHLORIDE EQ 300MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CIMETIDINE HYDROCHLORIDE EQ 300MG BASE/2ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA017939-002 · Discontinued
- CIMETIDINE HYDROCHLORIDE EQ 300MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SolutionThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA017924.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tagamet
- Active substance
- cimetidine hydrochloride
- Route
- Oral
- Dosage form
- Solution
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 16 Aug 1977
- Application
- NDA017924-001